Ronovo Surgical, a global leader in next-generation surgical robotics, announced the appointment of Dr. Eduardo Parra-Davila and Jeroen M.M. van Heesewijk as Non-Executive Directors to its Board of Directors. These appointments are expected to strengthen Ronovo’s governance, support its international growth strategy, and bring valuable expertise to the company’s long-term plans.
Health Technology Insights: Hippocratic AI Accelerates Team Growth and Key Executive Hires
Dr. Eduardo Parra-Davila is a highly respected general surgeon with over 25 years of experience and more than 5,000 robotic surgery procedures. He currently serves as Chief of General Surgery and Director of Minimally Invasive Colorectal Surgery and Hernia/Abdominal Wall Reconstruction at Good Samaritan Medical Center in West Palm Beach, Florida. A founding member of both the Society of Robotic Surgery and the Clinical Robotic Surgery Association, Dr. Parra-Davila has trained thousands of surgeons worldwide in minimally invasive and robotic techniques. He is also an active contributor to leading professional organizations including the American College of Surgeons, the Society of American Gastrointestinal and Endoscopic Surgeons, the American Hernia Society, and the American Society of Colon and Rectal Surgeons.
Health Technology Insights: Auna and Sojitz Partner to Expand Healthcare in Latin America
Jeroen M.M. van Heesewijk brings over 30 years of leadership experience in the medical devices sector. His background includes seven years in Europe and 15 years in China in senior management positions. He most recently served as Senior Vice President for Asia Pacific and Global Distribution at Intuitive. Prior to that, he held multiple executive roles at Philips, including Vice President of Strategic Business Development for Philips Medical Systems Asia Pacific, President of Philips Medical Systems Greater China, and General Manager of Philips operations in the Balkans, Romania, and Bulgaria. With academic training in international law and international relations, Mr. van Heesewijk possesses extensive knowledge of corporate governance and global business strategy.
Dr. John Ma, Founder, Chairman, and CEO of Ronovo Surgical, said that welcoming Dr. Parra-Davila and Mr. van Heesewijk to the Board demonstrates the company’s commitment to robust corporate governance and accelerating global expansion. He emphasized that their combined clinical and industry experience will be instrumental in guiding Ronovo’s strategy and delivering long-term value for stakeholders.
Health Technology Insights: Quanterix Strengthens Leadership with Board Appointments
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
